147 related articles for article (PubMed ID: 34912636)
1. Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy.
Easwaran TP; Sterling D; Ferreira C; Sloan L; Wilke C; Neil E; Shah R; Chen CC; Dusenbery KE
Cureus; 2021 Nov; 13(11):e19496. PubMed ID: 34912636
[TBL] [Abstract][Full Text] [Related]
2. GammaTile Brachytherapy Combined With External Beam Radiation Therapy for the Treatment of a Partially Resected Secondary Glioblastoma (WHO Grade 4 IDH-Mutant Astrocytoma): Matching External Beam Dose Gradient to Brachytherapy Dose Fall-Off.
Peach MS; Burke AM; Jo J; Ju AW; Yang K
Cureus; 2021 Nov; 13(11):e19717. PubMed ID: 34934580
[TBL] [Abstract][Full Text] [Related]
3. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract][Full Text] [Related]
4. Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles.
Mehta S; Vassantachart AK; Fossum CC; Yang W; Shen ZL; Chang KE; Ye JC; Chen TC; Chang EL
Cureus; 2021 Nov; 13(11):e19573. PubMed ID: 34926045
[TBL] [Abstract][Full Text] [Related]
5. GammaTile for Gliomas: A Single-Center Case Series.
Budnick HC; Richardson AM; Shiue K; Watson G; Ng SK; Le Y; Shah MV
Cureus; 2021 Nov; 13(11):e19390. PubMed ID: 34925992
[TBL] [Abstract][Full Text] [Related]
6. GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis.
Dharnipragada R; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
Neurooncol Adv; 2023; 5(1):vdad062. PubMed ID: 37324216
[TBL] [Abstract][Full Text] [Related]
7. First application of GammaTile cesium-131 brachytherapy with maximal safe resection of a glioma in a patient with limited scleroderma.
Pasli M; Cowles S; Jo J; Yaqoub M; Kanaan HA; Ju AW; Peach MS
J Contemp Brachytherapy; 2023 Oct; 15(5):365-371. PubMed ID: 38026076
[TBL] [Abstract][Full Text] [Related]
8. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
Garcia MA; Turner A; Brachman DG
J Neurooncol; 2024 Jan; 166(2):203-212. PubMed ID: 38261141
[TBL] [Abstract][Full Text] [Related]
9. Novel combination of GammaTile cesium-131 brachytherapy with 5-aminolevulinic acid fluorescence-guided resection in the re-irradiation of pediatric recurrent high-grade glioma: illustrative case.
Gordon JA; Pasli M; Cook CM; Connor R; Boyer PJ; Ju AW; Lee KS; Knudson KE; Peach MS
J Neurosurg Case Lessons; 2023 Oct; 6(16):. PubMed ID: 37870768
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy.
McClelland S; Gardner UG; Le Y; Ng SK; Shah MV; Watson GA
Brachytherapy; 2021; 20(6):1265-1268. PubMed ID: 34588144
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
12. Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method.
Arsenault T; Labak CM; Chaung K; Muzic RF; Kardan A; Sloan A; Choi S; Podder T; Ouyang Z
Cureus; 2021 Nov; 13(11):e19232. PubMed ID: 34877209
[TBL] [Abstract][Full Text] [Related]
13. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
14. GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors.
Ekhator C; Nwankwo I; Rak E; Homayoonfar A; Fonkem E; Rak R
Cureus; 2022 Oct; 14(10):e29970. PubMed ID: 36225241
[TBL] [Abstract][Full Text] [Related]
15. GammaTile
Gessler DJ; Ferreira C; Dusenbery K; Chen CC
Future Oncol; 2020 Oct; 16(30):2445-2455. PubMed ID: 32618209
[TBL] [Abstract][Full Text] [Related]
16. Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu HK; Olson J; Hoang K
Cureus; 2021 Nov; 13(11):e19777. PubMed ID: 34950555
[TBL] [Abstract][Full Text] [Related]
17. First clinical implementation of GammaTile permanent brain implants after FDA clearance.
Ferreira C; Sterling D; Reynolds M; Dusenbery K; Chen C; Alaei P
Brachytherapy; 2021; 20(3):673-685. PubMed ID: 33487560
[TBL] [Abstract][Full Text] [Related]
18. GammaTile® brachytherapy in the treatment of recurrent glioblastomas.
Gessler DJ; Neil EC; Shah R; Levine J; Shanks J; Wilke C; Reynolds M; Zhang S; Özütemiz C; Gencturk M; Folkertsma M; Bell WR; Chen L; Ferreira C; Dusenbery K; Chen CC
Neurooncol Adv; 2022; 4(1):vdab185. PubMed ID: 35088050
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
